Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
Status:
Terminated
Trial end date:
2018-12-18
Target enrollment:
Participant gender:
Summary
This Phase 3, multicenter, randomized, masked, controlled, parallel group study is designed
to demonstrate that suprachoroidal (SC) CLS-TA administered with intravitreal (IVT) anti-VEGF
agent in subjects with treatment naive RVO is superior to IVT anti-VEGF agent used alone.